Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Medtronic
Farmers Insurance
Express Scripts
Moodys
Queensland Health
Chinese Patent Office
McKinsey
US Army

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040226

« Back to Dashboard

NDA 040226 describes PERPHENAZINE, which is a drug marketed by Pharm Assoc, Ani Pharms Inc, Mylan Pharms Inc, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sandoz Inc, Sun Pharm Industries, and Watson Labs, and is included in forty-five NDAs. It is available from twelve suppliers. Additional details are available on the PERPHENAZINE profile page.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 040226
Tradename:PERPHENAZINE
Applicant:Vintage Pharms
Ingredient:perphenazine
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 040226
Ingredient-typePhenothiazines
Medical Subject Heading (MeSH) Categories for 040226
Suppliers and Packaging for NDA: 040226
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERPHENAZINE perphenazine TABLET;ORAL 040226 ANDA Par Pharmaceutical 0603-5060 N 0603-5060-28
PERPHENAZINE perphenazine TABLET;ORAL 040226 ANDA Par Pharmaceutical 0603-5060 N 0603-5060-21

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Dec 31, 1998TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Dec 31, 1998TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Dec 31, 1998TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKesson
Fish and Richardson
Fuji
UBS
Baxter
Citi
Colorcon
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.